Title: Cellular and molecular mechanisms of anti-inflammatory effect of Aflapin: a novel Boswellia serrata extract.
Journal: Molecular and cellular biochemistry 20110801
Title: Acetyl-11-keto-β-boswellic acid suppresses invasion of pancreatic cancer cells through the downregulation of CXCR4 chemokine receptor expression.
Journal: International journal of cancer 20110701
Title: Antistaphylococcal and biofilm inhibitory activities of acetyl-11-keto-β-boswellic acid from Boswellia serrata.
Journal: BMC microbiology 20110101
Title: Boswellic acid suppresses growth and metastasis of human pancreatic tumors in an orthotopic nude mouse model through modulation of multiple targets.
Journal: PloS one 20110101
Title: A novel anticancer agent, retigeric acid B, displays proliferation inhibition, S phase arrest and apoptosis activation in human prostate cancer cells.
Journal: Chemico-biological interactions 20101205
Title: [Acetyl-11-keto-beta-boswellic acid and arsenic trioxide regulate the productions and activities of matrix metalloproteinases in human skin fibroblasts and human leukemia cell line THP-1].
Journal: Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine 20101101
Title: 11beta-Hydroxysteroid dehydrogenase 1 inhibiting constituents from Eriobotrya japonica revealed by bioactivity-guided isolation and computational approaches.
Journal: Bioorganic & medicinal chemistry 20100215
Title: 3-Acetyl-11-keto-beta-boswellic acid loaded-polymeric nanomicelles for topical anti-inflammatory and anti-arthritic activity.
Journal: The Journal of pharmacy and pharmacology 20100201
Title: Permeation of Boswellia extract in the Caco-2 model and possible interactions of its constituents KBA and AKBA with OATP1B3 and MRP2.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20090215
Title: Antiinflammatory and antiatherogenic effects of the NF-kappaB inhibitor acetyl-11-keto-beta-boswellic acid in LPS-challenged ApoE-/- mice.
Journal: Arteriosclerosis, thrombosis, and vascular biology 20080201
Title: Effect of acetyl 11-keto beta-boswellic acid on metastatic growth factor responsible for angiogenesis.
Journal: Vascular pharmacology 20070501
Title: Co-administration of acetyl-11-keto-beta-boswellic acid, a specific 5-lipoxygenase inhibitor, potentiates the protective effect of COX-2 inhibitors in kainic acid-induced neurotoxicity in mice.
Journal: Pharmacology 20070101
Title: Boswellic acids stimulate arachidonic acid release and 12-lipoxygenase activity in human platelets independent of Ca2+ and differentially interact with platelet-type 12-lipoxygenase.
Journal: Molecular pharmacology 20060901
Title: Separation and quantification of terpenoids of Boswellia serrata Roxb. extract by planar chromatography techniques (TLC and AMD).
Journal: Journal of separation science 20060901
Title: Acetyl-11-keto-beta-boswellic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing NF-kappa B and NF-kappa B-regulated gene expression.
Journal: Journal of immunology (Baltimore, Md. : 1950) 20060301
Title: Potentiation of antinociceptive effect of NSAIDs by a specific lipooxygenase inhibitor, acetyl 11-keto-beta boswellic acid.
Journal: Indian journal of experimental biology 20060201
Title: 3-O-acetyl-11-keto-boswellic acid decreases basal intracellular Ca2+ levels and inhibits agonist-induced Ca2+ mobilization and mitogen-activated protein kinase activation in human monocytic cells.
Journal: The Journal of pharmacology and experimental therapeutics 20060101
Title: Protective effects of nimesulide (COX Inhibitor), AKBA (5-LOX Inhibitor), and their combination in aging-associated abnormalities in mice.
Journal: Methods and findings in experimental and clinical pharmacology 20050901
Title: Bioactive constituents from Boswellia papyrifera.
Journal: Journal of natural products 20050201
Title: Acetyl-11-keto-beta-boswellic acid (AKBA) is cytotoxic for meningioma cells and inhibits phosphorylation of the extracellular-signal regulated kinase 1 and 2.
Journal: Advances in experimental medicine and biology 20020101
Title: Acetyl-boswellic acids are novel catalytic inhibitors of human topoisomerases I and IIalpha.
Journal: Molecular pharmacology 20000701
